Cabot Corp. (CBT) — Fair Value Analysis

Base-case fair value (P50): $106.89 · Current price: $87.88 · Verdict: Undervalued

The Verdict on CBT

CABOT CORP (CBT) is currently undervalued based on our Monte Carlo simulations, which project a median fair value (P50) of $106.89. This assessment suggests a significant +21.6% upside from the current trading price of $87.88. Our analysis, incorporating thousands of forward scenarios, indicates that the market is not fully reflecting CBT's intrinsic value, presenting a compelling opportunity for investors seeking exposure to undervalued equities. The disparity between the current market price and our fair value estimate underpins this undervalued verdict for CBT.

How CBT stacks up against peers

Despite operating in a sector currently designated "n/a," CBT's operational and financial health is assessed as average when compared to its broader market context. This average quality tier, combined with the projected +21.6% from $87.88 to the $106.89 median fair value, suggests that CBT offers an attractive risk/reward profile. Even with an average quality standing, the substantial upside to its fair value indicates that its fundamental performance, while not exceptional, is robust enough to warrant a higher valuation than its current market price of $87.88.

What this means for investors

The undervalued status of CBT, with a median fair value of $106.89 against its $87.88, points to a strong potential for capital appreciation, highlighted by the +21.6%. While a downside scenario is always possible, our Monte Carlo analysis heavily favors an upward trajectory to fair value. Investors considering CBT should recognize this significant potential upside. For a comprehensive understanding of the full bear and bull distribution, and to track CBT's fair value as new fundamentals are released, sign up for a free FairCurve account.